or Try an Advanced Search...

    Technical Analysis for INTS - Intensity Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 4.70 -3.09% -0.15
    INTS closed down 3.09 percent on Friday, July 26, 2024, on 67 percent of normal volume. It ran into resistance at its 50 day moving average. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical INTS trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    50 DMA Resistance Bearish 0.00%
    Shooting Star Candlestick Bearish 0.00%
    180 Bearish Setup Bearish Swing Setup 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    BB Squeeze + Lower Band Touch Range Contraction 0.00%
    Gapped Down Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    20 DMA Resistance Bearish -3.09%
    Older End-of-Day Signals for INTS ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 17 hours ago
    50 DMA Resistance about 17 hours ago
    20 DMA Resistance about 17 hours ago
    10 DMA Resistance about 17 hours ago
    Down 3% about 17 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    INTS Chart by TradingView
    Basic chart:

    Profile

    intensity therapeutics is a connecticut based biopharmaceutical company whose mission is to create safer and more efficacious chemotherapy treatments. intensity therapeutics is a preclinical, in vivo stage company seeking investors interested in helping to advance the company’s technology and products.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Pharmacy Chemotherapy

    Is INTS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jul 9 Intensity Therapeutics, Inc. Announces First Patient Dosed in its Global Randomized, Phase 3 Study (INVINCIBLE-3) in Metastatic Soft Tissue Sarcoma
    Jun 6 Will Intensity Therapeutics (NASDAQ:INTS) Spend Its Cash Wisely?
    May 15 Intensity Therapeutics, Inc. Announces the Appointment of Thomas Dubin to Its Board of Directors
    May 14 Intensity Therapeutics: A Bargain For A Late-Stage Company With A Remarkable Oncology Drug
    Apr 2 Intensity Therapeutics to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024
    Mar 26 Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares
    Mar 14 Intensity Therapeutics GAAP EPS of -$1.38
    Mar 14 Intensity Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
    Mar 14 Intensity Therapeutics to Participate in the 36th Annual Roth Conference March 17 to 19, 2024
    Feb 21 Intensity Therapeutics to Present at the 2024 BIO CEO & Investor Conference
    See more INTS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.44
    52 Week Low 2.03
    Average Volume 14,605
    200-Day Moving Average 4.54
    50-Day Moving Average 4.89
    20-Day Moving Average 4.85
    10-Day Moving Average 4.82
    Average True Range 0.21
    RSI (14) 44.44
    ADX 19.03
    +DI 11.17
    -DI 21.13
    Chandelier Exit (Long, 3 ATRs) 4.48
    Chandelier Exit (Short, 3 ATRs) 5.22
    Upper Bollinger Bands 5.04
    Lower Bollinger Band 4.66
    Percent B (%b) 0.1
    BandWidth 7.79
    MACD Line -0.02
    MACD Signal Line 0.01
    MACD Histogram -0.0229
    Fundamentals Value
    Market Cap 64.43 Million
    Num Shares 13.7 Million
    EPS -0.74
    Price-to-Earnings (P/E) Ratio -6.35
    Price-to-Sales 0.00
    Price-to-Book 3.07
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.07
    Resistance 3 (R3) 5.10 5.01 5.01
    Resistance 2 (R2) 5.01 4.91 4.99 4.99
    Resistance 1 (R1) 4.85 4.85 4.80 4.82 4.97
    Pivot Point 4.76 4.76 4.73 4.74 4.76
    Support 1 (S1) 4.60 4.66 4.56 4.58 4.43
    Support 2 (S2) 4.51 4.60 4.49 4.41
    Support 3 (S3) 4.35 4.51 4.39
    Support 4 (S4) 4.33